Schmitt D, Akkari M, Mura T, Mondain M, Uziel A, Venail F
Département d'ORL et CMF, CHU Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier, France.
Département d'ORL et CMF, CHU Gui-de-Chauliac, 80, avenue Augustin-Fliche, 34295 Montpellier, France.
Eur Ann Otorhinolaryngol Head Neck Dis. 2018 Apr;135(2):105-110. doi: 10.1016/j.anorl.2017.09.008. Epub 2017 Dec 28.
There is at present no consensus on the treatment of obstructive Eustachian tube dysfunction. In case of failure of well-conducted drug and pressure therapy, some authors recommend balloon dilation; the present study aimed to assess the efficacy and safety of Eustachian tube balloon dilation.
A single-center retrospective study assessed clinical and tubomanometric results of Eustachian tube balloon dilation, complications and satisfaction in a consecutive series managed between June 2012 and February 2015. Indications were based on clinical and paraclinical signs of obstructive tube dysfunction despite well-conducted medical treatment.
Forty-five procedures were performed in 38 patients. Improvement in clinical symptoms was assessed as 88%, 80% and 80% at respectively 2 months, 6 months, and>1 year. Improved function on tubomanometry was observed in 81% of cases. The procedure was well tolerated, with a minor complications rate of only 4%.
The present findings for efficacy, tolerance and safety were comparable to those in the literature, despite first-line failure in all patients. Eustachian tube function normalized in about one-third of cases. Despite these encouraging results, true efficacy remains to be confirmed in prospective studies with higher levels of evidence.